During the past decade, Southern California Permanente Medical Group conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 21 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 10 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern California Permanente Medical Group" #1 sponsor was "Children's Oncology Group" with 12 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Telik" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern California Permanente Medical Group" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "Children's Oncology Group" with 3 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Southern California Permanente Medical Group" are "Leukemia" (6 trials), "Sarcoma" (5 trials), "Breast Cancer" (4 trials), "Ovarian Neoplasms" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "Southern California Permanente Medical Group" in a lesser frequency.

Most popular intervention types in "Southern California Permanente Medical Group" are "Drug" (62 trials), "Biological" (13 trials), "Device" (8 trials), "Other" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "etoposide" (8 trials), "vincristine sulfate" (7 trials), "cyclophosphamide" (5 trials) and "leucovorin calcium" (5 trials). Other intervention names were less common.

The vast majority of trials in "Southern California Permanente Medical Group" are 62 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Southern California Permanente Medical Group". undefined are not yet recruiting, 4 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Southern California Permanente Medical Group, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Southern California Permanente Medical Group, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".